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Elucidation of the role of PtdIns(4,5)P2 in epithelial function has been hampered by the inability to selectively 
  manipulate the cellular content of this phosphoinositide. Here we report that SigD, a phosphatase derived from 
Salmonella, can effectively hydrolyze PtdIns(4,5)P2, generating PtdIns(5)P. When expressed by microinjecting 
cDNA into epithelial cells forming confl  uent monolayers, wild-type SigD induced striking morphological and func-
tional changes that were not mimicked by a phosphatase-defi  cient SigD mutant (C462S). Depletion of PtdIns(4,5)P2 
in intact SigD-injected cells was verifi  ed by detachment from the membrane of the pleckstrin homology domain of 
phospholipase Cδ, used as a probe for the phosphoinositide by conjugation to green fl  uorescent protein. Single-
cell measurements of cytosolic pH indicated that the Na+/H+ exchange activity of epithelia was markedly inhibited 
by depletion of PtdIns(4,5)P2. Similarly, anion permeability, measured using two different halide-sensitive probes, 
was depressed in cells expressing SigD. Depletion of PtdIns(4,5)P2 was associated with marked alterations in the 
actin cytoskeleton and its association with the plasma membrane. The junctional complexes surrounding the in-
jected cells gradually opened and the PtdIns(4,5)P2-depleted cells eventually detached from the monolayer, which 
underwent rapid restitution. Similar observations were made in intestinal and renal epithelial cultures. In addition 
to its effects on phosphoinositides, SigD has been shown to convert inositol 1,3,4,5,6-pentakisphosphate (IP5) into 
inositol 1,4,5,6-tetrakisphosphate (IP4), and the latter has been postulated to mediate the diarrhea caused by 
  Salmonella. However, the effects of SigD on epithelial cells were not mimicked by microinjection of IP4. In contrast, 
the cytoskeletal and ion transport effects were replicated by hydrolyzing PtdIns(4,5)P2 with a membrane-targeted 
5-phosphatase or by occluding the inositide using high-avidity tandem PH domain constructs. We therefore sug-
gest that opening of the tight junctions and inhibition of Na+/H+ exchange caused by PtdIns(4,5)P2 hydrolysis 
combine to account, at least in part, for the fl  uid loss observed during Salmonella-induced diarrhea.
INTRODUCTION
Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) 
has long been recognized as an important source of sec-
ond messengers. Hydrolysis of PtdIns(4,5)P2 by phos-
pholipase C yields diacylglycerol, a potent activator of 
most protein kinase C isoforms and other enzymes bear-
ing C1 domains, and inositol 1,4,5-trisphosphate, which 
induces release of calcium stored in the endoplasmic 
reticulum (Taylor, 2002). In addition, phosphorylation 
of PtdIns(4,5)P2 by class I phosphatidylinositol 3-kinases 
generates phosphatidylinositol 3,4,5-trisphosphate, a 
  ligand and activator of various effectors that contain 
pleckstrin homology (PH) domains (Vanhaesebroeck 
et al., 2001; Lemmon, 2003). Not only are its meta-
bolites critical for signal transduction, but PtdIns(4,5)P2 
itself serves multiple regulatory functions in the cell. 
It affects several stages of actin microfi  lament assembly 
and remodeling, including uncapping of barbed ends, 
severing and bundling of fi  laments, and de novo nucle-
ation (Hilpela et al., 2004; Roth, 2004). In addition, several 
studies have shown that a variety of ion channels and 
exchangers are directly modulated by the local concen-
tration of PtdIns(4,5)P2 (Leung et al., 2000; Hilgemann 
et al., 2001; Hilgemann, 2003).
The functional importance of the metabolites gener-
ated from PtdIns(4,5)P2 has been convincingly estab-
lished by pharmacological means. Potent and reasonably 
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specifi  c phospholipase C and protein kinase C inhibitors 
are available, which have been used to evaluate the physio-
logical role of diacylglycerol, inositol 1,4,5-  trisphosphate 
(IP3), and their effectors (Botelho et al., 2000; Matsui 
et al., 2001; Spitaler and Cantrell, 2004). Similarly, class I 
phosphatidylinositol 3-kinases can be selectively inhib-
ited by wortmannin or LY294002 to assess the effects of 
phosphatidylinositol 3,4,5-trisphosphate biosynthesis 
(Vieira et al., 2001; Djordjevic and Driscoll, 2002). By 
contrast, establishing the function of PtdIns(4,5)P2 has 
proven to be considerably more diffi  cult. No specifi  c in-
hibitors of the kinases that generate this phosphoinosit-
ide have been described, and the coexistence of multiple 
kinase isoforms and splice variants has precluded ge-
netic analysis. Defi  nitive confi  rmation of the involve-
ment of PtdIns(4,5)P2 in the regulation of ion channels 
and transporters stems largely from electrophysiological 
studies in excised patches or perfused cells, where the 
cytosolic aspect of the membrane can be accessed   directly 
by solutions containing varying amounts of PtdIns(4,5)P2 
or bacterial lipases (Estacion et al., 2001; Loussouarn 
et al., 2003; Oliver et al., 2004). The multiple actions 
of PtdIns(4,5)P2 in cytoskeletal dynamics have been 
similarly gleaned primarily from studies of disrupted 
cells (Nebl et al., 2000; Hsin-Yi et al., 2004).
Remarkably little is known about the role of PtdIns 
(4,5)P2 in epithelial structure and function. The bar-
rier and vectorial transport functions of epithelia are 
eminently dependent on the maintenance of the in-
tegrity of individual cells and of their intercellular 
contacts. This requirement rules out the use of most 
of the techniques that have been successfully applied 
to study PtdIns(4,5)P2 function in other systems. Be-
cause molecular or genetic manipulation of the kinases 
that generate PtdIns(4,5)P2 is subject to the limitations 
  described above, we considered instead the possibility 
of modulating the cellular PtdIns(4,5)P2 content by 
expression of phosphoinositide-specifi  c phosphatases. 
Some success has been reported using Inp54p, a yeast 
inositol polyphosphate 5′-phosphatase (Raucher et al., 
2000). In our hands, however, this enzyme, as well as 
the native forms of the mammalian phosphoinositide 
phosphatases synaptojanin, SKIP and OCRL, had negli-
gible effects on the PtdIns(4,5)P2 content of epithelial 
cells (unpublished data). Failure of the phosphatases to 
target to the plasmalemma and/or to become activated 
likely account for these observations.
We reported that SigD/SopB, an injected virulence 
factor of Salmonella species, altered the binding of a 
PtdIns(4,5)P2-specifi  c PH domain to the inner leafl  et of 
the plasma membrane in HeLa cells (Terebiznik et al., 
2002). We now present evidence that SigD/SopB (re-
ferred to hereafter as SigD) functions as a 4’-phosphatase 
that dephosphorylates PtdIns(4,5)P2 to form PI(5)P. By 
cloning this bacterial phosphatase into a mammalian 
expression vector we were able to introduce it by micro-
injection into intact epithelia, which are notoriously 
  refractory to transfection. This strategy enabled us to 
analyze the consequences of selective depletion of 
PtdIns(4,5)P2 in confl  uent epithelia. Because Salmonella 
is an enteric pathogen that injects SigD along with 
  several other products into host epithelial cells via a 
type III secretion system encoded by the Salmonella 
pathogenicity island (SPI)-I (Galan, 1998), we focused 
our study primarily on IEC-18 cells, a line derived from 
the rat small intestine (Ma et al., 1992). In this manner, 
we simultaneously learned about the possible conse-
quences of Salmonella infection on intestinal physiology.
MATERIALS AND METHODS
Materials and Solutions
IP4 was purchased from Matreya Inc. Biochemicals. Rhodamine-
phalloidin, 4’,6-diamidino-2-phenyl-indole (DAPI), FM4-64, 
SNARF-5F,  N-(ethoxycarbonylmethyl)-6-methoxyquinolinium 
bromide (MQAE), and Alexa 568 microinjection dye were from 
Molecular Probes. Radiolabeled [32P]γATP and [3H]-myoinositol 
were from MP Biomedicals (formerly ICN Biomedicals). The 
Na+/H+ exchanger (NHE) inhibitors HOE694 and S3226 were 
gifts of Hoechst and Aventis, respectively. FBS, α-modifi  ed Earle’s 
medium (MEM), Dulbecco’s modifi  ed Eagle’s medium (DMEM), 
HEPES-buffered solution RPMI-1640 (HPMI), PBS, and penicil-
lin plus streptomycin were from Wisent. Antibodies to ZO-1 were 
purchased from Zymed Laboratories. Monoclonal antibodies 
against active caspase 3 were from BD Biosciences. Cy3-conju-
gated secondary antibodies were from Jackson ImmunoResearch 
Laboratories. All other reagents were from Sigma-Aldrich. Micro-
injection buffer consisted of (in mM) 140 KCl plus 10 HEPES, 
pH 7.4 at 37°C and was fi  lter sterilized before use. Na+-rich solution 
contained 130 NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, 20 HEPES, pH 7.4 
at 37°C. In K+-rich solution, all NaCl was replaced by KCl, and in 
Cl−-depleted solution NaCl was replaced by NaI or NaNO3.
Cell Culture
HeLa, IEC-18, and OK cells were obtained from the American 
Tissue Culture Collection. IEC-18 cells were grown in DMEM sup-
plemented with 5% FBS and 0.1 U/ml bovine pancreatic insulin. 
HeLa cells were grown in DMEM supplemented with 10% FBS. 
OK cells were grown in α-MEM supplemented with 10% FBS. All 
cells were maintained under 5% CO2 at 37°C. When required, 
cells were pretreated with 100 μM LY294002 for 30 min and the 
inhibitor was kept in the medium throughout the experiment.
DNA Constructs
The mammalian expression vectors encoding wild-type SigD and 
the inactive SigD mutant (C462S) have been described elsewhere 
(Marcus et al., 2001). The vector pEGFP::PLCδPH encodes the 
PH domain of PLCδ fused to EGFP (PLCδ-PH-GFP). pGFP::PM 
encodes the myristoylation/palmitoylation sequence from Lyn 
fused to GFP (PM-GFP). Both of these were the gift of T. Meyer 
(Stanford University, Stanford, CA) and their construction has 
been described before (Teruel et al., 1999). 2FYVE -GFP consists 
of two tandem FYVE domains from EEA1 conjugated to GFP and 
has been described previously (Vieira et al. 2001). The 2(PLCδ-
PH)-GFP construct was made by combining two tandem PLCδ-PH 
domains to GFP and was a gift of M. Rebecchi (State University of 
New York, Sunnybrook, NY). The phosphatase domain of mam-
malian synaptojanin 2 fused to a CAAX box modeled after the 
  carboxy terminal sequence of K-Ras (PD-CAAX) was the gift of   Mason et al. 269
M. Symons (The Feinstein Institute for Medical Research, Manhasset, 
NY). The construction of this construct has been detailed 
  previously (Malecz et al., 2000). The plasmid encoding the anion-
sensitive mutant of the yellow fl  uorescent protein YFP(H148Q) 
was described in Jayaraman et al. (2000).
Bacterial Culture and Infection Protocol
The source and properties of wild-type and SigD-defi  cient Salmo-
nella enterica serovar Typhimurium, (∆sigD) SL1344, were de-
scribed previously (Terebiznik et al., 2002). For complementation 
analysis, the ∆sigD mutant of S. Typhimurium SL1344 was trans-
formed with plasmid pACYC184 encoding either wild-type or the 
catalytically inactive C462S mutant of SigD (Marcus et al., 2001). 
That the level of expression of the wild-type and mutant SigD was 
similar in the bacterial strains used was verifi  ed by immunoblot-
ting, using a polyclonal anti-SigD antibody. Overnight bacterial 
cultures were diluted 1:30 into Luria-Bertani broth and incubated 
at 37°C, shaking for 3 h. Bacteria were sedimented at 10,000 g for 
2 min and then resuspended in HPMI, pH 7.4. 1 ml of bacterial 
suspension was added to cells that had been plated on 10-cm 
dishes and preincubated with 1 ml of HPMI at 37°C for 5 min. 
  Infection was performed at 37°C under 5% CO2. After 10 min, 
  excess bacteria were washed away with PBS and the cells subjected 
to lipid extraction as detailed below.
Lipid Extraction and Phosphoinositide Analysis
Lipid labeling and extraction were performed essentially as de-
scribed by Carricaburu et al. (2003). In brief, HeLa cells were la-
beled with 20 μCi/ml [3H]-myoinositol for 24–48 h in inositol-free 
medium. After labeling, the cells were washed free of excess iso-
tope, infected with the indicated strain of Salmonella for 15 min, 
and immediately lysed in 1 M HCl. Lipids were next extracted in 
chloroform:methanol (1:1, vol:vol) and deacylated as described 
(Serunian et al.,1991). Deacylated lipids were separated by anion-
exchange high performance liquid chromatography (HPLC), 
detected by an online Radiomatic detector (Perkin Elmer), and 
quantifi  ed relative to PtdIns using the ProFSA analysis program. 
Individual peaks in the chromatogram were identified using 
in   vitro–synthesized internal standard lipids.
For analysis of phosphatidylinositol 5-phosphate (PtdIns(5)P) 
the cells were treated as specifi  ed in the text and phospholipids 
were extracted in acidifi  ed chloroform:methanol as in Niebuhr 
et al. (2002). The lipid extracts were dried under nitrogen and 
used subsequently for determination of PtdIns(5)P content by the 
method of Morris et al. (2000). In brief, PtdIns(5)P was converted 
to PtdIns(4,5)P2 in vitro by addition of phosphatidylinositol 
5-phosphate 4-kinase and 32P-γATP. The products of this reaction 
were separated by thin layer chromatography (TLC) and the 
amount of radiolabeled PtdIns(4,5)P2 quantifi  ed. The identity of 
the labeled product was confi  rmed to be PtdIns(4,5)P2 by analyz-
ing the samples using HPLC.
Microinjection Protocol
Cells were grown on 25-mm glass coverslips and used for experi-
ments 2 d after the monolayer had reached confl  uence. The cover-
slips were then transferred to a thermostatted Leiden chamber 
and incubated with HPMI medium supplemented with anti-
biotic/antimicotic mixture (1:500) for 30 min before microinjec-
tion. The microinjection solution contained 50 μg/ml of the 
indicated mixture of plasmids, typically a 5 to 1 ratio of SigD to 
PLCδ-PH-GFP cDNA. Microinjection was performed under phase 
contrast microscopy using an Eppendorf Transjector 5246 con-
trolled by an Eppendorf 5171 Micromanipulator. Microinjected 
cells were identifi  ed by the expression of the fl  uorescent protein 
products. To minimize evaporation during prolonged observa-
tion periods the chambers were sealed using a second coverslip 
secured with a small amount of silicon grease.
Cytosolic pH Determinations
For cytosolic pH determinations IEC-18 cells were microinjected 
with cDNA encoding YFP, with or without SigD cDNA. Cells were 
next incubated for 3 h at 37°C under 5% CO2 to allow expression 
of the proteins. Alternatively, the cells were loaded with SNARF-
5F by loading with 20 μM of the precursor acetoxymethyl ester for 
30 min. The coverslips were then mounted in a thermostatted 
Leiden holder, bathed in a Na+-rich buffer, and placed on the 
stage of a Leica fl  uorescence microscope equipped with a PL 
Fluotar 100×/1.30 N.A. oil immersion objective. Sutter fi  lter 
wheels positioned excitation and emission fi  lters in front of a Hg 
lamp and the acquisition camera, respectively. For YFP, excitation 
was at 480 nm and was directed to the cells through a 510-nm 
  dichroic mirror. Emitted fl  uorescence was selected through a 
535BP25-nm fi  lter. For SNARF-5F, excitation was at 550 nm and 
emission was recorded at 580 and 640 nm. Images were captured 
with an Orca ER cooled charge-coupled device camera (Hama-
matsu). Image acquisition was controlled by the Metafl  uor soft-
ware v3.5 (Universal Imaging Corp.). To determine background, 
an area identical to the region of interest was selected outside 
the transfected cell and fl  uorescence was acquired. At the end 
of the experiment, a calibration curve of fl  uorescence (ratio) vs. 
pH was obtained in situ by sequential perfusion with K+-rich me-
dium buffered to predetermined pH values (between 6.0 and 7.4) 
containing 10 μg/ml nigericin. Calibration curves were con-
structed by plotting the extracellular pH, assumed to be identical 
to the cytosolic pH under these conditions, against the corre-
sponding fl  uorescence.
To determine the relative contribution of specifi  c NHE iso-
forms, pH determinations were performed in the presence of 
1 μM HOE694 to selectively inhibit NHE1, 20 μM HOE694, to 
  inhibit both NHE1 and NHE2, or 20 μM HOE694 plus 5 μM of 
S3226, to inhibit the three main plasmalemmal isoforms.
Determinations of Anion Permeability
Anion permeability was estimated by two methods: fi  rst, the anion-
sensitive variant of YFP(H148Q) was used by a microfl  uorimetric 
method similar to that described above for pH determinations. 
Because YFP derivatives are also inherently sensitive to pH, a 
  second series of experiments was performed using a chloride-
  sensitive dye, N-(ethoxycarbonylmethyl)-6-methoxyquinolinium 
bromide (MQAE), which was loaded into the epithelial cells by 
hypotonic stress, following expression of SigD or the PD-CAAX 
construct. To identify the cells expressing the phosphatase, SigD 
was cotransfected with PLCδ-PH-GFP. By studying the presence 
and distribution of this construct we not only identifi  ed the trans-
fectants, but ensured that the phosphatase had in fact exerted 
its effects on PtdIns(4,5)P2. Control experiments were performed 
in cells expressing PLCδ-PH-GFP only. After loading hypotoni-
cally with MQAE, cells were allowed to recover in isotonic 
  medium for 30 min before measurement of anion permeability. 
TABLE I
Analysis of Phosphoinositide Content after Infection
Uninfected Salmonella Wild Type Salmonella ∆sigD
PtdIns(4,5)P2 8.2 ± 0.7% 5.3 ± 0.4% 6.9 ± 0.4%
PtdInsP 5.5 ± 0.7% 7.4 ± 0.9% 3.5 ± 0.2%
Phosphoinositide levels were quantifi  ed before (Uninfected) and after 
infection of HeLa cells with either wild-type or sigD-defi  cient  (∆sigD) 
Salmonella. Lipids were extracted and analyzed by HPLC as detailed in 
Materials and methods. The amount of the phosphoinositides is given as 
percent of PtdIns in the same sample. PtdInsP refers to the sum of both 
PtdIns(4)P and PtdIns(5)P, which are not resolved by the chromatographic 
system used. Data are means ± SEM of three separate experiments.270 Epithelial PtdIns(4,5)P2 Degradation by a Bacterial Phosphatase
Calibration was made using 10 μM nigericin and 10 μM tributyl-
tin chloride in K+-rich media of varying Cl− concentration.
Staining with Fluorescent Markers and Confocal Microscopy
Cells grown on coverslips were washed twice with PBS and fi  xed in 
4% paraformaldehyde in PBS at room temperature for at least 
30 min, followed by quenching of excess fi  xative with 100 mM 
  glycine for 10 min. Cells were blocked while permeabilized using 
5% skimmed milk in PBS containing 0.1% Triton X-100 for 
60 min. ZO-1 was immunostained using a polyclonal primary 
  antibody (1:100), followed by secondary Cy3-conjugated donkey 
anti-rabbit antibodies (1:1,000).
To label F-actin, fi  xed and permeabilized cells were stained 
with a 1:500 dilution of rhodamine-phalloidin for 30 min. Two 
different methods were used for assessment of apoptosis. In both 
cases the cells were fi  xed with 3% paraformaldehyde for 15 min at 
room temperature and, where indicated, permeabilized with 
0.1% saponin in PBS. For caspase-3 staining the preparation was 
blocked for 30 min in medium containing 10% donkey serum in 
PBS, and then incubated with antibody to active caspase-3 (1:200), 
followed by fl  uorescently conjugated secondary antibodies, each 
for 1 h. For DAPI staining, 5 μg/ml of the nuclear dye was added 
to the fi  xed and permeabilized cells, followed by incubation for 
30 min at room temperature. Coverslips were mounted onto 
slides using DAKO™, left to dry overnight in the dark at room 
temperature, and then stored at −20°C.
Both live and fi  xed samples were analyzed by conventional epi-
fl  uorescence microscopy using a Leica IRE DR2 inverted micro-
scope with an Orca II ER camera (Hamamatsu) driven by the 
Openlab 3 software (Improvision) installed on an Apple G4 com-
puter. Alternatively, analysis was made by confocal microscopy us-
ing a Zeiss LSM 510 laser scanning microscope with oil immersion 
objectives. Where indicated, the location of the plasma mem-
brane was defi  ned by addition of FM4-64 (20 μM) at the time of 
imaging. FM4-64 is a solvochromic red fl  uorescent dye that parti-
tions into the outer monolayer of the plasmalemma. GFP, Cy3, 
and FM4-64 were examined using the conventional laser excita-
tion lines and fi  lter sets.
Online Supplemental Material
The online suppelemental material (Figs. S1 and S2) is avail-
able at http://www.jgp.org/cgi/content/full/jgp.200609656/DC1. 
Fig. S1 shows the phosphoinositide changes induced by SigD. Lip-
ids were extracted from HeLa cells after invasion by wild-type or 
SigD-defi  cient Salmonella. Lipids were analyzed for phosphoinosit-
ide content using HPLC. Fig. S2 shows the effect of SigD in renal 
epithelial cells. The expression of SigD was studied in opossum 
kidney (OK) cells. Morphological changes were studied alongside 
PtdIns(4,5)P2 distribution as in Fig. 2.
RESULTS
SigD Hydrolyzes Phosphatidylinositol 4,5-Bisphosphate
SigD contains a domain with homology to mammalian 
inositol 4-phosphatases (Norris et al., 1998). We reported 
earlier that SigD induces the displacement of PLCδ-
PH-GFP, a ligand of PtdIns(4,5)P2, from the membrane 
of HeLa cells (Terebiznik et al. 2002) and interpreted 
these results to mean that the bacterial protein modi-
fi  ed PtdIns(4,5)P2 in a manner that rendered it unable 
to associate with the PH domain. However, SigD was 
also reported to act as an inositol polyphosphate phos-
phatase, capable of depleting cellular IP6 and inositol 
pyrophosphates and of converting IP5 into IP4 (Norris 
et al., 1998). The latter can in turn be converted to IP3, 
which interacts with high affi  nity with PH domains. It 
was thus conceivable that the displacement of PLCδ-PH-
GFP from the membrane occurred as a result of IP3 for-
mation, without alteration in PtdIns(4,5)P2.
To determine whether SigD displays catalytic activity 
toward phosphoinositides in vivo we analyzed the lipid 
composition of HeLa cells exposed to the phosphatase 
using HPLC. Phosphoinositides were labeled using 
[3H]-myoinositol and the cells were otherwise untreated 
(control) or were infected with Salmonella enterica serovar 
Typhimurium (S. Typhimurium) to obtain extensive and 
nearly synchronous delivery of bacterial proteins to 
the host cell cytosol, via their type-III secretion system. 
Cells were infected with either wild type or with sigD-
  defi  cient S. Typhimurium (∆sigD), in order to assess the 
contribution of the phosphatase. The inositide content 
data were normalized to the amount of PtdIns, the pre-
dominant species in mammalian cells, which is thought 
to be practically invariant. As shown in Table I, the 
PtdIns(4,5)P2 content of control cells was equivalent to 
8.2% of the PtdIns, in the range reported for other cells 
(Serunian et al., 1991). Infection for only 15 min with 
bacteria that express SigD (wild type) resulted in a 34% 
drop in the PtdIns(4,5)P2 content, to 5.3% of the   
PtdIns. The decrease was consistently observed in three 
independent experiments and was statistically signifi  -
cant (P < 0.05 using ANOVA-Bonferroni’s multiple 
comparison test). The large decrease in PtdIns(4,5)P2 
was absent when infection was performed using SigD-
defi  cient bacteria (Table I). In this case, the drop was 
considerably smaller and not signifi  cant (P > 0.05).
The preceding data are consistent with the notion 
that SigD actively dephosphorylates PtdIns(4,5)P2 to 
  PtdInsP. This was confi  rmed by analyzing the PtdInsP 
content of the samples (Table I). In untreated cells the 
major PtdInsP peak detected by HPLC, which is com-
prised of PtdIns(4)P plus PtdIns(5)P, constituted 5.5% 
of the PtdIns. Infection with bacteria expressing SigD 
resulted in a considerable increase in PtdInsP, to 7.4% 
of PtdIns. Notice that the magnitude of the increase 
in PtdInsP is similar to the decrease in PtdIns(4,5)P2 
  recorded under the same conditions, suggesting a pre-
cursor and product relationship. Importantly, the PtdInsP 
content was not increased when the cells were infec-
ted with SigD-defi  cient bacteria (Table I), confi  rming 
that the phosphatase is responsible for the generation of 
the inositide.
SigD Generates Phosphatidylinositol 5-Phosphate
Because SigD has homology to mammalian inositol 
4-phosphatases (Norris et al. 1998), the disappearance 
of PtdIns(4,5)P2 is likely the result of its conversion to 
phosphatidylinositol 5-phosphate (PtdIns(5)P). While 
the preceding data confi  rmed the near stoichiomet-
ric disappearance of PtdIns(4,5)P2 and concomitant   Mason et al. 271
  appearance of PtdInsP, the HPLC system used is unable 
to differentiate PtdIns(5)P from phosphatidylinositol 
4-phosphate (PtdIns(4)P). To test whether PtdIns(5)P 
is in fact formed we used a combined enzymatic and 
TLC assay that involves conversion of PtdIns(5)P to 
PtdIns(4,5)P2 by PtdIns(5)P 4-kinase. The identity of 
the product of the enzymatic reaction was validated by 
HPLC (for details see Materials and methods and Morris 
et al. [2000] and Niebuhr et al. [2002]). As above, to dis-
cern the contribution of SigD we compared the effects 
of wild-type Salmonella to those of mutants devoid of 
SigD. The deletion of sigD was verifi  ed by immunoblot-
ting (Fig. 1 B). As shown in Fig. 1 A, infection with wild-
type, but not SigD-defi  cient  Salmonella, generated a 
sizable amount of PtdIns(5)P, indicated by the forma-
tion of PtdIns(4,5)P2. That this difference between the 
two bacterial strains was due to the deletion of sigD 
was confi  rmed by reintroduction of the phosphatase 
into the defi  cient Salmonella. Transformation of (∆sigD) 
Salmonella with a plasmid encoding wild-type SigD restored 
the production of PtdIns(5)P upon infection (Fig. 1 A). 
Like other active phosphatases, SigD has an essential cys-
teine in its active site. We generated a plasmid encoding 
a mutant SigD where the critical cysteine was replaced 
by serine, namely SigD (C462S). SigD-defi  cient bacteria 
were then transformed with this plasmid and used to 
  infect mammalian cells. Immunoblotting was used to 
confi  rm that the level of expression of the mutant and 
wild-type forms of SigD was similar in the strains used 
(Fig. 1 B). Unlike the plasmid encoding wild-type SigD, 
the C462S mutant plasmid was unable to restore the 
  appearance of PtdIns(5)P (Fig. 1 C), confi  rming that 
the 4-phosphatase activity of the enzyme is responsible, 
at least in part, for the hydrolysis of PtdIns(4,5)P2.
In principle, PtdIns(5)P could have also been gener-
ated by dephosphorylation of PtdIns(3,5)P2 on position 3, 
as has been reported for myotubularins (Tronchere 
et al., 2004), or by sequential dual dephosphorylation 
of PtdIns(3,4,5)P3, a preferred substrate of SigD in vitro 
(Norris et al., 1998). Several lines of evidence argue 
against these possibilities. First, analysis by HPLC 
  revealed that the cellular content of PtdIns(3,5)P2 is far 
too low to account for the increase in PtdInsP. As shown in 
Fig. S1 A (available at http:// www.jgp.org/cgi/content/
full/jgp.200609656), the basal level of PtdIns(3,5)P2 is 
equivalent to ≈0.1% of the PtdIns, over 25 times lower 
than the increase in PtdInsP recorded in the same 
  experiments. It is unlikely that PtdIns(3,5)P2 is rapidly 
generated by other processes and simultaneously de-
graded by SigD, thus failing to accumulate. This is indi-
cated by the fi  nding that the PtdIns(3,5)P2 content 
of cells infected with SigD -defi  cient bacteria is also 
  extremely low, similar to that of untreated or wild-type 
Salmonella-infected cells (Fig. S1 A). Like PtdIns(3,5)P2, 
the content of PtdIns(3,4,5)P3 in resting cells is much 
too low (≈0.1% of PtdIns) to account for the formation 
of PtdInsP, did not decrease upon infection with wild-
type bacteria, and did not increase in cells infected with 
(∆sigD) bacteria (unpublished data).
Additional evidence against the involvement of 
PtdIns(3,5)P3 or PtdIns(3,4,5)P3 in the generation of 
PtdIns(5)P was obtained using LY294002. This com-
pound effectively inhibits both class I and class III   
PtdIns 3 kinases, which are required for the formation 
Figure 1.  Generation of PtdIns(5)P by SigD. HeLa cells were in-
fected with the indicated strains of Salmonella and, after 10 min 
at 37°C, the reaction was stopped and lipids were extracted as 
described in Materials and methods. The PtdIns(5)P content 
was  next analyzed by its enzymatic conversion to radiolabeled 
PtdIns(4,5)P2 by insertion of the gamma phosphate of [32P]ATP, 
catalyzed by the type II phosphoinositide kinase, which selectively 
phosphorylates the 4’-position of PtdIns(5)P. The resulting lipids 
were next separated by thin layer chromatography. A representa-
tive chromatogram is shown in A. The site where the lipid mix-
ture was spotted (Origin) and the position of the PtdIns(4,5)P2 
produced are indicated. The cells were infected, from left to 
right, with wild-type Salmonella, SigD-defi  cient Salmonella, SigD-
  defi  cient Salmonella bearing a plasmid expressing wild-type SigD 
cDNA, and SigD-defi  cient Salmonella bearing a plasmid express-
ing the catalytically inactive SigD mutant SigD (C462S). Lipids 
from uninfected cells are shown in the last lane. The deletion of 
SigD and the level of expression of the retransformed wild-type 
and mutant SigD were verifi   ed by immunoblotting. Identical 
amounts of bacteria were loaded, and lanes from the same gel 
and exposure are shown in B, which is representative of two simi-
lar blots. Lanes were separated in the image to facilitate align-
ment with the TLC (above) and bar graph (below). Molecular 
mass markers (in kD) are shown to the right. In C the amount of 
PtdIns(4,5)P2 present in each TLC sample was quantifi  ed  by 
HPLC and online continuous-fl  ow liquid-scintillation counting. 
The chromatogram and quantitation shown are representative of 
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of PtdIns(3,4,5)P3 and of PtdIns(3)P, the precursor of 
PtdIns(3,5)P2, respectively. Fig. S1 B shows that under 
the conditions used, LY294002 blocked PtdIns 3-kinase 
activity; endosomal PtdIns(3)P, detected using a tandem 
FYVE domain from EEA1, disappeared upon treat-
ment with the drug (panels B and B′). When cells were 
fi  rst treated with LY294002 and then infected with wild-
type Salmonella in the presence of the inhibitor, the gen-
eration of PtdIns(5)P persisted (Fig. S1 C).
Jointly, these observations provide convincing evidence 
that SigD from Salmonella is an effective phosphoinosi-
tide phosphatase capable of converting PtdIns(4,5)P2 to 
PtdIns(5)P. Whether the increase in PtdInsP measured 
by HPLC can be accounted for in its entirety by PtdIns(5)
P remains to be defi  ned, since the combined enzymatic/
TLC assay does not yield quantitative estimates. Never-
theless, it is clear that at least a fraction of the PtdInsP 
generated is PtdIns(5)P.
Effect of SigD on the PtdIns(4,5)P2 Content 
of Epithelial Cells
The IEC-18 cell line was used as an epithelial model for 
these studies for two reasons. First, it forms well-defi  ned 
polarized monolayers with distinct junctional com-
plexes (see below). Second, IEC-18 cells were derived 
from the small intestine, where Salmonella infection 
  occurs in humans. Thus, our studies could potentially 
yield both basic and pathophysiological information. 
Confl  uent epithelial monolayers are notoriously diffi  -
cult to transfect, and this was found to be the case for 
IEC-18 cells as well (unpublished data). To introduce 
cDNA into these cells without disrupting the integrity of 
the monolayer we opted instead to use microinjection. 
The number of cells that can be injected precluded bio-
chemical analyses but provided reproducible results 
when single cells were analyzed microscopically.
The PH domain of PLCδ has been used extensively to 
monitor PtdIns(4,5)P2 in live cells (Stauffer et al., 1998; 
Raucher et al., 2000; Varnai et al., 2002). The distribu-
tion of PLCδ-PH-GFP expressed in IEC-18 cells is illus-
trated in Fig. 2 (A–C). As anticipated from its association 
with PtdIns(4,5)P2, the construct is mostly bound to 
the inner aspect of the plasma membrane. Both the 
apical and basolateral membranes were comparably 
  labeled (see z-axis reconstruction in Fig. 2 A’). The plas-
malemmal association of PLCδ-PH-GFP is best visualized 
by confocal microscopy (Fig. 2 A) but can be readily 
appreciated also by conventional fl  uorescence micro-
scopy (Fig. 2 C). Note that microinjection and expres-
sion of PLCδ-PH-GFP had no discernible effect on 
Figure 2.  Effect of SigD on 
PtdIns(4,5)P2 distribution and 
cellular morphology. Intestinal 
epithelial cells (IEC-18) were 
microinjected with cDNA 
  encoding PLCδ-PH-GFP only 
(A–C), or together with ei-
ther wild-type SigD (D–F) or 
SigD (C462S) cDNA (G–I). 
Cells were then incubated 
for 3 h at 37°C before imag-
ing by confocal (A, D, and 
G), differential interference 
contrast (DIC; B, E, and H), 
or conventional epifl  uores-
cence microscopy (C, F and I). 
A, D, and G illustrate rep-
resentative x vs. y confocal 
slices acquired near the mid-
dle of the cell, while A′, D′, 
and G′ are the correspond-
ing x vs. z reconstructions. 
The DIC images in B, E, and 
H correspond to the cells in 
C, F, and I, respectively. The 
images are representative of 
at least 10 similar experiments 
of each type. Bar, 10 μm.  Mason et al. 273
IEC-18 cell morphology, as is evident from DIC micro-
scopy (Fig. 2 B).
The effect of SigD on PLCδ-PH-GFP distribution is 
shown in Fig. 2 (D–F). As early as 1 h after microinjec-
tion the phosphatase reverted the association of PLCδ-
PH-GFP with the membrane, rendering the construct 
largely cytosolic. The displacement was evident both by 
confocal (Fig. 2 D) and conventional microscopy (Fig. 
2 F). Line scans of images like those in Fig. 2 (A and D), 
followed by densitometry of the resulting scans were 
used to quantify the reproducibility and statistical 
  signifi  cance of the effect of SigD. The pixel density at 
the membrane, defi  ned by staining with FM4-64, was 
normalized to that of the cytosol. In seven similar de-
terminations the membrane-to-cytosol ratio averaged 
7.97 ± 1.4, while in SigD-treated cells it was 0.97 ± 0.01 
(data are mean values ± SEM). This difference is highly 
signifi  cant (P < 0.001). DIC imaging of SigD-injected 
cells revealed that they underwent extensive vacuola-
tion, and fl  uorescence microscopy indicated that these 
vacuoles are sealed, as they excluded PLCδ-PH-GFP. 
That the displacement of PLCδ-PH-GFP is due to the 
phosphatase activity of SigD was ascertained by micro-
injecting SigD(C462S). The inactive mutant had no 
detectable effect on the distribution of PLCδ-PH-GFP 
and failed to produce vacuolation (Fig. 2, G–I). Indeed, 
SigD(C462S)-injected cells were indistinguishable from 
the controls, implying that all the observed effects of 
wild-type SigD are attributable to its phosphoinositide 
phosphatase activity.
The effects of SigD were not restricted to intestinal 
epithelial cells, but were observed also in renal epithe-
lial cells. The accumulation of PLCδ-PH-GFP at the 
plasmalemma and its displacement by SigD were noted 
also in OK cells, an opossum kidney line (see Fig. S2). 
Together, the results of Fig. 2 and Fig. S2 confi  rm the 
effectiveness of SigD as a phosphoinositide phosphatase 
when introduced into mammalian cells and highlight 
its ability to deplete PtdIns(4,5)P2 in epithelial cells.
Effect of SigD on Epithelial Morphology and Integrity
In addition to the vacuolation reported in Fig. 2, other 
structural changes were consistently noted in cells ex-
pressing SigD. These changes developed gradually over 
time and were always preceded by displacement of 
PLCδ-PH-GFP from the membrane, suggesting that they 
were a consequence of the hydrolysis of PtdIns(4,5)P2. 
The development of the structural changes is illustrated 
in Fig. 3. Concomitantly with the appearance of vacu-
oles, cells injected with SigD extend lamellipodia be-
yond the original junctional complexes (see Fig. 3, B 
and B′, and Fig. 4 below). At later times blebbing of the 
apical surface is apparent (Fig. 3, C and C′). These blebs 
extend well beyond the surface of the monolayer and 
are in fact best detected when the focal plane of the 
  microscope is raised by 10 μm above the normal apical 
surface (Figs. 3, H and H′). Eventually, most of the 
PtdIns(4,5)P2-depleted cell bulges above the monolayer, 
rounding up (Fig. 3, D–I) and fi  nally  detaching 
from the epithelium. All of these effects depend on the 
Figure 3.  Time course of the 
effects of PtdIns(4,5)P2 de-
pletion on epithelial morphol-
ogy. Epithelial cells grown to 
confl  uence were used for mi-
croinjection of PLCδ-PH-GFP 
and SigD cDNA (1:5 ratio). 
Wild-type SigD was used in 
A–D and F–I, while SigD 
(C462S) was used in E and J. 
DIC and epifl  uorescence im-
ages were acquired with the 
focal plane near the apical 
surface of the cells (A–E) or 
≈10 μm above the apical 
  membrane (F–J). The images 
shown are representative of at 
least fi  ve similar experiments. 
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phosphatase activity of SigD, since they were never 
  observed in cells expressing SigD(C462S). As shown in 
Fig. 3 (E and J), such cells retained normal morphology 
and remained as integral components of the monolayer 
even after 5 h, when cells expressing wild-type SigD had 
generally bulged and rounded up.
Because PtdIns(4,5)P2 effectively modulates the actin 
cytoskeleton, we speculated that the morphological 
changes induced by SigD were due, at least in part, to 
alterations in actin fi  lament structure. To test this no-
tion cells were fi  xed and permeabilized at various times 
after microinjection with cDNA encoding SigD and 
PLCδ-PH-GFP. The cells were then stained with rhoda-
mine-phalloidin to reveal F-actin and analyzed by con-
focal microscopy (Fig. 4). These experiments indicated 
that actin underwent a biphasic change. At the early 
stages of action of SigD, the F-actin content of the cells 
seemingly increased, particularly in the lamellipodia 
that extended beyond the normal junctional boundaries 
(Fig. 4, A and B). At this stage, the SigD-injected cells 
remained within the context of the monolayer, though 
the stress fibers attaching them to the substratum 
were somewhat depleted (not depicted). Subsequently, 
bulging above the monolayer and vacuolation became 
apparent (panels C and D, labeled “mid-stage” in Fig. 4). 
At this time the lamellipodia had receded and the net 
F-actin content of the cells had diminished. At even 
later stages the vacuoles were resorbed and the cells 
rounded up and protruded above the monolayer (Fig. 4, 
E and F, labeled “late stage”), ultimately detaching. 
  Little F-actin remained at this stage, accounting for cell 
rounding. Of note, the neighboring cells rapidly oc-
cupied the space vacated by the PtdIns(4,5)P2-depleted 
cell, a form of epithelial restitution.
The Effects of SigD on the Cytoskeleton Are Mediated 
by Depletion of PtdIns(4,5)P2
As described above, the structural changes elicited by 
SigD were not mimicked by SigD(C462S). Because this 
inactive mutant also failed to alter PtdIns(4,5)P2, deple-
tion of the inositide is likely responsible for the ob-
served structural changes. However, it is also possible 
that accumulation of PtdIns(5)P is involved and, since 
SigD hydrolyzes several soluble inositol phosphates 
(Norris et al., 1998), generation of IP4 from IP5 is an-
other potential cause of the morphological changes. 
Figure 4. Effect of PtdIns
(4,5)P2 depletion on F-actin 
and PtdIns(4,5)P2 distribution. 
Intestinal epithelial cells (IEC-
18) were microinjected with 
PLCδ-PH-GFP and SigD cDNA 
(1:5 ratio). The monolayers 
were incubated for varying 
  periods of time and were 
then fi  xed,  permeabilized, 
and stained with rhodamine-
  phalloidin to reveal F-actin. 
The stained cells were then 
analyzed by confocal fl  uores-
cence microscopy. Panels A–F 
show PLCδ-PH-GFP in green 
and F-actin in red. Panels A′–F′ 
show only F-actin in white. 
Panels A, A′, C, C′, E, and E′ 
illustrate representative x vs. y 
confocal slices acquired near 
the middle of the cell, while 
B, B′, D, D′, F, and F′ are the 
corresponding x vs. z recon-
structions. A and B are repre-
sentative of cells fi  xed at an 
early stage, i.e., 2–4 h after 
injection. C and D are repre-
sentative of cells fi  xed at an 
intermediate stage, i.e., 4–5 h 
after injection. E and F are 
representative of cells fi  xed at 
a late stage, i.e., 5–6 h after in-
jection. The images shown are 
representative of 10 similar 
experiments of each type. Bar, 
10 μm.  Mason et al. 275
The latter possibility was analyzed by directly micro-
injecting the cells with IP4. The concentration of IP4 in 
the injection pipette was 100 μM. Because we estimate 
that the injection volume approximates 5–10% of the 
total cell volume, a fi  nal concentration of 5–10 μM IP4 
must have been delivered to the cells. This concentra-
tion is higher than the concentration of IP4 reported in 
cells infected by Salmonella (Zhou et al., 2001). In four 
experiments, injection of IP4 had no discernible effect 
on IEC-18 cell morphology or association with the mono-
layer (unpublished data). Similarly, microinjection of 
PtdIns(5)P or extracellular addition of this lipid in the 
presence of carriers that facilitate intracellular delivery 
of inositides was without effect on cell morphology 
  (unpublished data).
These observations suggest that depletion of 
PtdIns(4,5)P2, not production of PtdIns(5)P or IP4, was 
the cause of the morphological changes. To validate 
this conclusion, we manipulated PtdIns(4,5)P2 by two 
independent procedures. First, we transfected a phos-
phoinositide phosphatase of mammalian origin, synap-
tojanin-2. To improve the effi   ciency of hydrolysis, a 
construct encoding the phosphatase domain was tar-
geted to the membrane by addition of a prenylation 
motif, a polycationic sequence and CAAX box modeled 
after the C terminus of K-Ras. Expression of this con-
struct effectively displaced PLCδ-PH-GFP from the 
membrane (Fig. 5 A; see Fig. 2 A for comparison with un-
treated control), indicating hydrolysis of PtdIns(4,5)P2. 
More prolonged expression of the synaptojanin-2 phos-
phatase-CAAX construct induced cell blebbing (Fig. 5 B) 
and eventual detachment of the cells from the substra-
tum. In parallel, the actin cytoskeleton was drastically 
altered, with marked disappearance of stress fibers 
(Fig. 5 C).
We also tested the effects of overexpression of an avid 
PtdIns(4,5)P2 ligand, which at suffi  ciently high concen-
trations should mask a signifi  cant fraction of the inosit-
ide. To this end we used a construct of two tandem 
copies of the PH domain of PLCδ, which is predicted to 
have enhanced avidity for PtdIns(4,5)P2. As shown in 
Fig. 5 D, 2(PLCδ-PH)-GFP binds very effectively to the 
plasmalemmal PtdIns(4,5)P2 and, when expressed at 
high levels, induced cell blebbing (Fig. 5, D and E) 
and pronounced changes in cytoskeletal architecture 
(Fig. 5 F). Because the structural changes produced by 
synaptojanin-2 phosphatase-CAAX and 2(PLCδ-PH)-
GFP resemble those induced by SigD, we believe that 
diminution in the amount of available plasmalemmal 
PtdIns(4,5)P2 is the common underlying mechanism.
Effect of PtdIns(4,5)P2 Depletion on Tight 
Junction Integrity
Since tight junctions are necessary to maintain epithe-
lial integrity, which was lost upon expression of SigD, we 
suspected that depletion of PtdIns(4,5)P2 may have de-
stabilized the junctional complexes. This was tested by 
staining control and transfected monolayers with anti-
bodies to ZO-1, a well-established tight junction marker. 
As reported earlier (Ma et al., 1992), in confl  uent mono-
layers of IEC-18 cells ZO-1 was found to line the cellular 
junctions in a virtually continuous pattern (Fig. 6 A). 
Similar results were obtained in cells injected only with 
soluble or membrane-associated GFP constructs used 
as indicators of expression (not illustrated). Even at 
the early stages of the PtdIns(4,5)P2 depletion process 
Figure 5. Alternative  means 
of regulating PtdIns(4,5)P2. 
IEC-18 cells were micro-
injected with cDNA encoding 
for (A–C) the phosphatase 
domain of synaptojanin-2 
fused to a CAAX box (PD-
CAAX), or (D–F) two tandem 
copies of the PH domain 
from PLCδ-PH fused to GFP 
(see Materials and methods 
for details regarding use and 
construction). In A, the PD-
CAAX DNA was coexpressed 
with the PLCδ-PH-GFP to 
identify transfected cells and 
to ensure the PtdIns(4,5)P2 
hydrolysis occurred. (A and D) 
Green fl  uorescence; (B and E) 
DIC images. The cell in D 
corresponds to E; (C and F) 
actin staining using phalloidin. 
Arrows indicate injected cells.276 Epithelial PtdIns(4,5)P2 Degradation by a Bacterial Phosphatase
(1–3 h after injection) disruption of the junctional in-
tegrity was apparent, as judged by the discontinuities in 
the ZO-1-staining pattern (Fig. 6, B and C). Preferential 
staining with ZO-1 at the cell boundary was completely 
eliminated at later stages. A disruption of ZO-1 architec-
ture was also observed in cells expressing the synapto-
janin-CAAX construct as well as in cells with high levels 
of 2(PLCδ-PH)-GFP expression. Importantly, the effect 
of SigD injection on junctional integrity was absent 
when the phosphatase-inactive mutant SigD(C462S) 
was used ( unpublished data), pointing to depletion of 
PtdIns(4,5)P2 as the underlying mechanism.
Does SigD Induce Apoptosis of Epithelial Cells?
The blebbing and rounding observed in cells express-
ing SigD is also characteristic of apoptotic cells (Majno 
and Joris, 1995). Moreover, infection with Salmonella has 
been reported to promote apoptosis of some cell types 
(Knodler and Finlay, 2001). It was therefore important 
to establish whether depletion of PtdIns(4,5)P2 by SigD 
suffi  ced to trigger programmed cell death in IEC-18 
cells. To this end, cells were coinjected with SigD or 
SigD(C462S) and a fl  uorescent protein, used as an in-
jection and expression marker. Apoptosis was initially 
assessed from nuclear morphology in cells stained with 
DAPI. A very small fraction of the uninjected cells 
(1–2%) had an apoptotic phenotype, consistent with fi  nd-
ings in other cells (Majno and Joris, 1995). The sensitiv-
ity of the detection procedure was validated treating the 
cells with 100 nM of staurosporine for 2 or 5 h, which 
increased the apoptotic index to 13.4% and 34.9%, 
  respectively. More importantly, when comparing over 
100 cells from three experiments no signifi  cant increase 
in the fraction of apoptotic cells was detected in SigD-
  expressing cells (2%), even at the longest times tested. 
Longer times were not investigated, as the cells tended 
to detach from the monolayer (see Fig. 3).
DAPI staining is simple, yet not the most sensitive 
method for detection of apoptosis. Gross changes in 
nuclear morphology occur only in advanced stages of 
apoptosis and the time window of our experiments may 
have been insuffi  cient to reach such stages. For this rea-
son, we also assessed apoptosis using a more sensitive 
method that detects earlier stages of programmed cell 
death. Control and SigD-expressing cells were stained 
with a specifi  c antibody that recognizes the activated 
form of caspase-3, an essential early component of the 
apoptotic chain. As in the case of DAPI, no signifi  cant 
difference in the fraction of apoptotic profi  les was mea-
sured in four determinations between control and SigD-
expressing cells (2% vs. 1%) while distinct apoptosis 
was observed following a short treatment with stauro-
sporine (10.5% after 2 h). Jointly, these experiments 
  indicate that apoptosis is not prevalent during the fi  rst 
4–6 h of expression of SigD, at a time when PtdIns(4,5)P2 
is extensively degraded and cell morphology is drasti-
cally altered. These results are consistent with the fi  nd-
ings of Santos et al. (2001), who determined that SigD 
was not required for the induction of apoptosis in host 
cells in an animal model of Salmonella infection.
Effect of PtdIns(4,5)P2 Depletion on Anion Permeability
In the context of the intestinal epithelium, transient 
opening of the junctional complexes would be pre-
dicted to result in loss of vectorial ion transport and pos-
sibly cause diarrhea (Uzzau and Fasano, 2000). Indeed, 
Figure 6.  Effect of PtdIns(4,5) 
P2 depletion on junctional 
  integrity. Intestinal epithelial 
cells (IEC-18) were either 
  untreated (A) or were micro-
injected with PM-GFP, a fl  uo-
rescent microinjection and 
expression marker together 
with SigD cDNA (B and C). 
The monolayer was incubated 
for 2 h to allow expression 
and then fi  xed,  permeabi-
lized, and stained with anti-
bodies to ZO-1, followed by 
Cy3-coupled secondary anti-
bodies. The cells were the 
  analyzed by fl  uorescence mi-
croscopy. Red fl  uorescence is 
shown in A and C and green 
in B. Arrows point to regions 
where junctional staining is 
discontinuous. Images are 
representative of fi  ve similar 
experiments. Bar, 10 μm.  Mason et al. 277
SigD has been identifi  ed as a principal factor in causing 
diarrhea in animal models of Salmonella infection 
(Galyov et al., 1997). However, the loss of fl  uid was not 
attributed to loss of junctional integrity, but was instead 
proposed to be caused by increased Cl− secretion in 
  response to elevated levels of IP4 (Norris et al., 1998). 
This conclusion, however, was derived from studies of 
chloride infl  ux into nonepithelial (HEK293) cells and 
  required validation in epithelia.
We implemented measurements of anion permeabil-
ity using a novel halide-responsive variant of the yellow 
fl  uorescent protein, YFP(H148Q). This protein responds 
to variations in halide concentration with changes in 
pKa that, at constant pH, translate into fl  uorescence 
changes (Jayaraman et al., 2000). IEC-18 cells were 
  microinjected with the cDNA encoding YFP(H148Q), 
together with or without SigD. A typical measure-
ment is illustrated in Fig. 7 A, where the concentra-
tion of Cl− in the medium was varied stepwise, by 
isoosmotic replacement with I−. The latter anion is a 
more effective quencher of YFP(H148Q) emission, 
resulting in a progressive diminution of fluorescence. 
The loss was largely, but not entirely reversible, due to 
photobleaching incurred during repeated acquisitions. 
Indeed, a comparable partial decrease was noted upon 
repeated illumination at constant [Cl−]. The bleaching 
component could be readily interpolated and cor-
rected in our measurements. Finally, tributyltin and 
  nigericin were used to calibrate the fl  uorescence vs. 
[Cl−]. Using this approach, we were able to compare 
the rates of halide exchange in control cells and in cells 
expressing SigD. Cells were tested at the early and mid 
stages of expression, but not at the late stages (see 
Fig. 3), because the tenuous attachment of the latter to 
the monolayer made measurements unreliable and 
  calibration impossible. The data collected from 11 
  determinations are summarized in Fig. 7 B. Contrary to 
the predictions made on the basis of the work of Feng 
et al. (2001), we found that halide permeability was in 
fact depressed by SigD.
Because GFP-derived probes such as YFP(H148Q) can 
be affected by environmental parameters other than the 
halide concentration, including the pH, it was impera-
tive to ascertain that this unexpected discrepancy did 
not result from an experimental artifact. We therefore 
performed an independent set of experiments using a 
Figure 7.  Effect of PtdIns(4,5)P2 
depletion on anion permeability. 
(A and B) IEC-18 cells were micro-
injected with YFP(H148Q), a halide-
sensitive fl   uorescent protein with 
or without wild-type SigD cDNA. 
The cells were allowed to express 
the   fl  uorescent probe for 2 h and 
subjected to digital imaging for 
  assessment of halide permeability 
as described under Materials and 
methods. (A) Representative exper-
iment. The emission of YFP(H148Q) 
is shown over time in a cell not ex-
pressing SigD. Where indicated, the 
concentration of chloride in the 
bathing medium was reduced by 
isoosmotic replacement with iodide. 
For calibration, the cells were per-
meabilized using tributyltin (TBT) 
and nigericin. (B) Quantitation of 
relative chloride permeability in 
cells expressing either YFP(H148Q) 
alone (control) or in combination 
with SigD. The rate of change of the 
fl  uorescence over time (ΔF/t) was 
calculated following reduction of 
chloride to 0 mM by isoosmotic 
  replacement with iodide. To allow 
comparison between experiments 
the fl  uorescence was normalized to 
the initial (maximal) value. Data 
are means ± SEM of 11 individual 
cells from three separate experiments. (C and D) Cells were microinjected with SigD cDNA as above or alternatively with the PD-CAAX 
construct and subsequently loaded hypotonically with MQAE as detailed in Materials and methods. Following a 30-min recovery period, 
the chloride concentration was manipulated using nitrate as a substitute and calibrated as in A. (D) Quantitation of the rate of change 
of MQAE fl  uorescence over time in control cells (open bar) with SigD (fi  lled bar) or with PD-CAAX (gray bar). Data are means ± SEM 
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different chloride-sensitive probe, MQAE. While sensi-
tive to halide concentrations, MQAE fl  uorescence is not 
altered by the physiological anions HCO3
−, SO4
2−, and 
PO4
3−, by cations, or by pH (Verkman et al., 1989). 
  Results of a typical experiment are shown in Fig. 7 C and 
the summary of 10 determinations from three separate 
experiments is presented in Fig. 7 D. As found using 
YFP(H148Q), the MQAE results indicate that anion per-
meability is diminished by treatment with SigD. To 
  ensure that this diminution was caused by hydrolysis of 
PtdIns(4,5)P2, as opposed to dephosphorylation of ino-
sitol polyphosphates, we also tested the effects of PD-
CAAX on chloride permeability. As shown in Fig. 7 D 
(gray bar), this membrane-associated, phosphoinositide-
specifi  c phosphatase produced an inhibition comparable 
to that seen with SigD, ruling out mediation by hydrolysis 
of soluble inositol polyphosphates. These fi  ndings are 
not consistent with elevated Cl− secretion as the mecha-
nism underlying SigD-induced diarrhea and, in addi-
tion, suggest a role for PtdIns(4,5)P2 in the modulation 
of epithelial anion transport.
Effect of PtdIns(4,5)P2 Depletion on Na+/H+ Exchange
The apical membranes of intestinal and renal epithe-
lial cells are active sites of Na+ resorption. Much of this 
absorption occurs in exchange for H+ and is coupled 
to Cl−/HCO3
− exchange and to osmotically obliged 
fl  uid absorption. There is evidence in model systems 
that some isoforms of the NHE are sensitive to the con-
centration of PtdIns(4,5)P2 (Aharonovitz et al., 2000; 
Fuster et al., 2004), though this has not been validated 
for epithelial cells. The possible regulation of epithe-
lial exchangers by PtdIns(4,5)P2 is important not 
only in the context of Salmonella infection, but also be-
cause PtdIns(4,5)P2 can vary during signaling, changes 
in cell volume, and ischemia. We therefore took ad-
vantage of the selective phosphatase activity of SigD 
and PD-CAAX to investigate the specifi  c effects of 
PtdIns(4,5)P2 depletion on Na+/H+ exchange activity 
in epithelial cells.
Epithelial cells often coexpress multiple isoforms of 
NHE. To our knowledge, the isoforms present in IEC-18 
cells have not been defi  ned. Therefore, we fi  rst assessed 
the overall NHE activity of these cells and estimated the 
contribution of the “housekeeping” NHE1 isoform and 
of specialized isoforms like NHE2 and NHE3. NHE 
  activity was assessed as the Na+-induced recovery of the 
cytosolic pH from an acid load. Cytosolic acidifi  cation 
was imposed using an ammonium prepulse, as previously 
described (Aharonovitz et al., 2000). Preliminary exper-
iments revealed that IEC-18 cells have a robust exchange 
activity (Fig. 8 A, a sample trace is shown in B, triangles). 
Figure 8.  Effect of PtdIns(4,5)P2 depletion pH regulation. To 
measure pH, IEC-18 cells were microinjected with YFP cDNA 
with or without wild-type SigD cDNA. The cells were allowed to 
express the proteins for 2 h. Alternatively, cells microinjected 
with PLCδ-PH-GFP with or without wild-type SigD or PD-CAAX 
cDNA were loaded with SNARF-5F during the fi  nal 30 min of the 
expression period. The cells were then subjected to digital imag-
ing for assessment of cytosolic pH, as described under Materials 
and methods. (A) To defi  ne the functional contribution of indi-
vidual NHE isoforms, the rate of pH recovery was measured in 
SNARF-5F–loaded cells treated with the indicated inhibitors. 
From left: untreated cells; cells treated with 1 μM HOE694 (ex-
pected to inhibit NHE1 almost exclusively); cells treated with 
20 μM HOE694 (expected to inhibit both NHE1 and NHE2); 
cells treated with 20 μM HOE694 plus 5 μM S3226 (expected to 
inhibit NHE1, NHE2 and NHE3). (B) Representative experiment 
showing pH recovery from an acid load in YFP (solid triangles) 
and YFP plus SigD-expressing cells (open circles). The emission 
of YFP was calibrated using nigericin and potassium, and the pH 
determined from such calibrations is shown over time. The cells 
were prepulsed with ammonium to induce cytosolic acidifi  cation 
upon its removal. Where indicated, sodium in the bathing 
  medium was replaced isoosmotically by potassium and vice versa. 
(C) Quantitation of relative Na+/H+ exchange activity of con-
trol, SigD-expressing, or PD-CAAX–expressing cells. Activity was 
  measured as the rate of sodium-induced pH recovery, measured 
over the fi  rst 1–2 min. Data show rates of alkalinization and are 
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The contribution of individual isoforms to this response 
was investigated using HOE694, an inhibitor that differ-
entially affects various NHE isoforms. At low (≤1 μM) 
concentrations, HOE694 selectively blocks NHE1, while 
at higher concentrations (20 μM) it also blocks NHE2. 
Under these conditions, NHE3 is largely unaffected 
(Counillon et al., 1993). A different inhibitor has the 
converse effect; at 5 μM S3226 preferentially inhibits 
NHE3. As shown in Fig. 8 A, 82% of Na+/H+ exchange 
in IEC-18 cells was blocked by 1 μM HOE694. The frac-
tional inhibition was not increased when 20 μM HOE694 
was used, but an additional 11% was inhibited when 
5  μM S3226 was added. These fi  ndings imply that 
Na+/H+ exchange in IEC-18 cells is largely mediated 
by NHE1, with a smaller contribution by NHE3. No 
NHE2 activity was detectable in these cells.
We proceeded to assess the effect of PtdIns(4,5)P2 de-
pletion on exchange activity. As for Cl− determinations, 
cells were tested at early and mid stages of expression, 
but not at the late stages, because the tenuous attach-
ment of the latter to the monolayer made calibration 
impossible. Indeed, late stage cells become permeant to 
H+ equivalents and could not be acid loaded to the 
same degree as control cells. As illustrated in Fig. 8 
(B and C), depletion of PtdIns(4,5)P2 by expression of 
SigD produced inhibition of NHE activity, which be-
came more pronounced at the later stages of expres-
sion of this phosphatase. A signifi  cant inhibition of 
the antiport was also observed when cells were trans-
fected with PD-CAAX, confi   rming that physiological 
PtdIns(4,5)P2 levels are required for optimal NHE activ-
ity. These fi  ndings are in accord with the inositide sensi-
tivity reported in nonepithelial model systems expressing 
NHE1 (Aharonovitz et al., 2000; Fuster et al., 2004) and 
NHE3 (Fuster et al., 2004).
DISCUSSION
SigD Is a PtdIns(4,5)P2 Phosphatase
The biological activity of SigD was fi  rst inferred from its 
sequence homology with mammalian phosphoinositol 
phosphatases (Norris et al., 1998). Its ability to dephos-
phorylate inositol phosphates was then demonstrated 
in vitro and cells expressing SigD were found to accu-
mulate IP4. It was subsequently appreciated, however, 
that SigD is largely membrane bound (Marcus et al., 
2002), not an ideal location for the degradation of solu-
ble substrates. Its subcellular location suggested that 
the degradation of inositol phosphates may not be the 
sole or even the most important function of SigD and 
prompted investigators to test whether it can addition-
ally hydrolyze phosphoinositides. This notion was tested 
by in vitro experiments that were met with positive, yet 
confl   icting, results; different groups confi  rmed  that 
SigD is active against phospholipids, but the substrate 
selectivity varied among reports (Norris et al. 1998; 
  Marcus et al., 2001; Hernandez et al., 2004).
The fi  rst indication that SigD effectively cleaves phos-
pholipids when introduced into mammalian cells was 
provided by Terebiznik et al. (2002), who described dis-
sociation of PLCδ-PH-GFP from the cytosolic face of the 
membrane in cells infected by wild-type, but not SigD-
defi  cient,  Salmonella. More recently, the appearance 
of PtdIns(3)P in Salmonella-containing vacuoles was 
also attributed to the lipid phosphatase activity of SigD 
(Hernandez et al., 2004). Here we provide direct biochem-
ical evidence of phosphoinositide conversion induced 
by SigD. Cells infected by Salmonella were found to have 
a markedly elevated content of 4’ and/or 5′-phosphoryl-
ated PtdInsP, which corresponded quantitatively to 
the concomitant decrease in PtdIns(4,5)P2.
At least a fraction of the product was PtdIns(5)P, a 
lipid that is expressed in minute amounts in untreated 
cells. The increase in PtdIns(5)P induced by SigD is 
strongly reminiscent of the effect of IpgD, a Shigella viru-
lence factor that bears considerable sequence homology 
(38.5%) with SigD. IpgD concomitantly produced deple-
tion of PtdIns(4,5)P2, pointing to dephosphorylation of 
this inositide at the 4’ position as the source of PtdIns(5)P. 
Indeed, like SigD, IpgD bears a region of homology with 
mammalian inositol 4-phosphatases (Norris et al., 1998). 
Thus, both the Shigella and Salmonella phosphatases 
  appear to target primarily PtdIns(4,5)P2 and, as such, 
are very useful tools to study the functional requirement 
for this phosphoinositide in animal cells.
Tools for the Manipulation of PtdIns(4,5)P2 in Intact 
Mammalian Cells
While phospholipids were initially thought to serve 
mainly a structural role, they are now believed to partici-
pate in signaling, vesicular traffi  c, and cytoskeleton reg-
ulation. Some of these suggested functions have been 
deduced from in vitro experiments but require verifi  ca-
tion in intact cells. Such verifi  cation has been most diffi  -
cult, largely because selective manipulation of specifi  c 
inositides has proven extremely complex. In the case of 
PtdIns(4,5)P2, several strategies have been attempted. 
Metabolic inhibition has been found to be paralleled by 
depletion of PtdIns(4,5)P2. However, the specifi  city of 
this manipulation is questionable, in view of the myriad 
ATP-dependent events in cells. PtdIns(4,5)P2 is often 
depleted acutely by activation of phospholipase C using 
calcium ionophores (Varnai and Balla, 1998). As in the 
case of ATP depletion, however, the pleiotropic effects 
of calcium elevation make assignment of functional 
consequences ambiguous. More specifi  c effects can, in 
principle, be obtained using phosphoinositide-specifi  c 
phosphatases. Several 5-phosphatases have been identi-
fi  ed and reported to cleave PtdIns(4,5)P2. We have 
tested heterologous overexpression of OCRL and 
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(unpublished data). This may be attributed to the sub-
cellular location of these enzymes, which are found mostly 
in endomembranes (Gurung et al., 2003; Ungewickell 
et al., 2004). In our hands, heterologous expression of 
Inp54p, a 5-phosphatase from yeast, had only minor 
  effects on epithelial cells. We were similarly disappointed 
by the effects of overexpressed full-length synaptojanin 
(unpublished data), even though this phosphatase is 
found at the plasma membrane (McPherson et al., 1996). 
It is conceivable that synaptojanin, and possibly the 
other 5-phosphatases as well, require the coexpression 
of ancillary factors and/or are regulated by heretofore 
unidentifi  ed mechanisms.
A constitutively active phosphatase that does not re-
quire cofactors and is not subject to regulation would 
be more suitable to acutely manipulate PtdIns(4,5)P2. 
Our observations suggest that bacterial 4-phosphatases, 
such as SigD and IpgD, fulfi  ll these requirements and 
have ample activity to induce massive degradation of 
PtdIns(4,5)P2 in a variety of mammalian cells. These en-
zymes can be expressed heterologously in eukaryotic 
cells by introduction of the available cDNAs, and re-
combinant proteins could in principle be used for micro-
injection when even more acute effects are desired. 
Unlike the synaptojanin-CAAX construct, the bacterial 
phosphatases do not require posttranslational modifi  ca-
tions, which facilitates recombinant expression and ac-
celerates generation of the active protein in transfected 
cells. It must be borne in mind that both SigD and IpgD 
generate PtdIns(5)P in the plasmalemma as they de-
grade PtdIns(4,5)P2 and that this product may have bio-
logical activity, although none has been described to 
date and we failed to observe any effects following intra-
cellular delivery of PtdIns(5)P. Nevertheless, a bioactive 
role for PtdIns(5)P cannot be ruled out.
Effects of PtdIns(4,5)P2 Depletion on Epithelial Structure 
and Function
Expression of SigD was accompanied by marked changes 
in the structure of epithelial cells. These were likely 
caused by the depletion of plasmalemmal PtdIns(4,5)P2, 
since neither PtdIns(5)P nor IP4, the known products 
of SigD activity, were able to recapitulate the structural 
changes. Evidence that PtdIns(4,5)P2 depletion can al-
ter the actin cytoskeleton was provided by Raucher et al. 
(2000), who used optical tweezers to measure mem-
brane tether forces in nonpolarized cells expressing 
Inp54p, a 5-phosphatase from yeast. Our results express-
ing synaptojanin-CAAX and 2(PLCδ-PH)-GFP are also 
consistent with a requirement for normal levels of 
PtdIns(4,5)P2 to maintain intact the epithelial structure.
The effects of PtdIns(4,5)P2 depletion on cytoskeletal 
architecture followed a peculiar time course. At the ear-
liest stages, the cells emitted apical lamellipodial exten-
sions, and this coincided with extensive vacuolation. 
Subsequently, stress fi  bers disappeared gradually as the 
overall F-actin content diminished and the cells ulti-
mately underwent blebbing and rounding as they pro-
truded from the monolayer. Inactivation of ezrin likely 
contributed to disruption of the apical structure, since 
this protein is thought to anchor transmembrane pro-
teins to actin fi  bers in a manner that is stimulated by 
PtdIns(4,5)P2 (Bretscher et al., 2002). The perijunc-
tional actin band was also depleted upon hydrolysis of 
PtdIns(4,5)P2 and this was associated with loss of ZO-1 
staining, consistent with junctional uncoupling. The 
loss of cell–cell contacts can readily explain the extru-
sion of the SigD-transfected cells from the context of 
the epithelial monolayer. To our knowledge, this is the 
fi  rst evidence that tight junctional integrity depends on 
the availability of PtdIns(4,5)P2.
We also assessed the consequences of PtdIns(4,5)P2 
depletion on a limited number of physiological para-
meters characteristic of epithelia. First, we noted that 
Na+/H+ exchange was severely depressed by reducing 
the level of the phosphoinositide. These observations 
are in good agreement with earlier reports in non-
epithelial model systems (Aharonovitz et al., 2000; Fuster 
et al., 2004) and emphasize the multiplicity of actions of 
PtdIns(4,5)P2. It remains unclear whether the effects of 
the phospholipid are exerted directly or via intermedi-
ate proteins like ezrin (Baumgartner et al., 2004). In 
any event, it is clear that conditions predicted to alter 
PtdIns(4,5)P2, such as ischemia or infection by Salmo-
nella or Shigella, will be accompanied by reduced salt 
and water absorption and may thus contribute to over-
all fl  uid loss during diarrhea (see below).
Contribution of PtdIns(4,5)P2 Loss to Diarrhea Induced 
by Pathogenic Bacteria
The occurrence of diarrhea is one of the major clinical 
complications of infection by Salmonella. Targeted dele-
tion experiments initially demonstrated that the bacte-
rial factors responsible for the fl  uid loss resided in the 
fi  rst pathogenicity island of the Salmonella genome (SPI 1). 
Further refi  nements of the deletional analysis indicated 
that the effector proteins SipA, SopA, SigD/SopB, 
SopD, and SopE2 act in concert to induce diarrhea 
(Zhang et al., 2002). The individual contribution of 
each of these proteins has not been thoroughly defi  ned, 
but SigD is believed to be a major effector and has there-
fore been studied in most detail. In particular, it has 
been proposed that SigD contributes to fl  uid loss by 
stimulation of intestinal chloride secretion, and this 
  effect was postulated to be mediated by IP4 (Feng et al., 
2001). The rationale for this proposal is based on the 
earlier report that PtdIns(3,4,5)P3 acts as an inhibitor of 
calcium-dependent chloride secretion (Eckmann et al., 
1997). By competing with PtdIns(3,4,5)P3, IP4 was pro-
posed to relieve this inhibition, unmasking chloride 
  secretion. In support of this hypothesis, Feng et al. 
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cells  promoted an increase in chloride permeability. How-
ever, this hypothesis appears unlikely on the following 
grounds. (a) Chloride secretion is not constitutive and 
requires an increase in cytosolic calcium above the basal 
level. Indeed, the inhibitory effect of PtdIns(3,4,5)P3 is 
exerted on the secretion induced by muscarinic agents, 
but is not expected to occur in otherwise unstimulated 
cells. (b) The purported inhibitory effect of IP4 requires 
competition with existing PtdIns(3,4,5)P3. However, the 
resting levels of apical PtdIns(3,4,5)P3 in unstimulated 
cells are very low, insuffi  cient to raise basal calcium by 
activation of phospholipase Cγ (Melendez et al., 1999) 
or of Tec-family kinases, if present (Carpenter, 2004). 
(c) Shigella, which is related to Salmonella and produces 
a similar diarrhea, was reported by Eckmann et al. 
(1997) not to generate IP4. (d) Lastly, the reported ef-
fects of SigD on chloride permeability appear not to be 
universal and, importantly, were not observed in intesti-
nal epithelial cells in our experiments. Jointly, these 
considerations detract from the weight that should be 
given to IP4 and chloride secretion as contributing fac-
tors to Salmonella-induced diarrhea.
The experiments presented here suggest alternative 
mechanisms. First, depletion of PtdIns(4,5)P2 by SigD 
resulted in inhibition of Na+/H+ exchange activity, 
which is predicted to depress the rate of sodium and 
water absorption (by inhibition of NHE3) and compro-
mise intracellular pH homeostasis (by inhibition of 
NHE1). At later stages, cells expressing SigD lost F-actin 
and underwent opening of their junctional complexes. 
The ensuing transient increase in transepithelial con-
ductance could readily account for decreased fl  uid ab-
sorption. Indeed, junctional opening has been invoked 
in the etiology of diarrhea in both bacterial and viral 
  infections (Dickman et al., 2000; Goosney et al., 2000; 
Bertelsen et al., 2004).
Clearly, though informative, microinjection of SigD 
into IEC-18 cells is not a perfect model of bacterial in-
fection. This paradigm is useful in that it enabled us to 
isolate the contribution of SigD to the bacterial effec-
tor phenotype. On the other hand, neither the inten-
sity nor the duration of the effects of expressed SigD 
are likely to be identical to those it exerts during bac-
terial infection. In the heterologous expression system 
SigD is likely to localize to both apical and basolateral 
membranes, which may not be the case during infec-
tion. Lastly, though derived from the rat ileum (Ma 
et al., 1992), IEC-18 cells are not perfect mimics of the 
primary epithelium. Nevertheless, the information ob-
tained revealed the potential of SigD to exert a variety 
of biological effects, the contribution of which to the 
pathogenicity of the bacteria will need to be validated 
in vivo.
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